Drawing for ADAKVEO

USPTO serial 79100532

ADAKVEO

Reviewed by CopyMark Law Group

Reg. 4152348Status 404
Filing date
Status date
Registration date
Jun 5, 2012
Examiner
BORSUK, ESTHER
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ADAKVEO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maury M. Tepper, III

Maury M. Tepper, III Tepper & Eyster, PLLC3724 Benson DriveRaleigh, NC 27609UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for use in dermatology; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceuticals, namely, anti-infectives; Vaccines; Diagnostic preparations for medical useSECTION 70 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 2, 2021RNWLINTERNATIONAL REGISTRATION RENEWED
Mar 1, 2019GPNXNOTIFICATION PROCESSED BY IB
Jun 2, 2018DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Jun 1, 2018DETHDEATH OF INTERNATIONAL REGISTRATION
Jun 5, 2017REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Apr 13, 2013NREPNEW REPRESENTATIVE AT IB RECEIVED
Mar 4, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Feb 23, 2013ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB
Sep 10, 2012FICSFINAL DISPOSITION NOTICE SENT TO IB
Sep 10, 2012FIMPFINAL DISPOSITION PROCESSED
Sep 5, 2012FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 5, 2012R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 20, 2012NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 20, 2012PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 29, 2012NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 10, 2012PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 7, 2012CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Feb 6, 2012TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Feb 6, 2012CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 26, 2012ALIEASSIGNED TO LIE
Jan 16, 2012TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 12, 2011ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 12, 2011REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 3, 2011RFNTREFUSAL PROCESSED BY IB
Sep 15, 2011RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 15, 2011RFRRREFUSAL PROCESSED BY MPU
Sep 14, 2011RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 13, 2011CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 7, 2011DOCKASSIGNED TO EXAMINER
Aug 19, 2011MAFRAPPLICATION FILING RECEIPT MAILED
Aug 15, 2011NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 11, 2011REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance